v3.24.2.u1

License Agreements (Details) - USD ($) |  |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended |
--- | --- | --- | --- | --- | --- | --- | ---
Nov. 22, 2021 | Aug. 30, 2021 | Dec. 08, 2020 | Dec. 31, 2021 | Jan. 31, 2021 | Dec. 31, 2020 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 21, 2021
Capitalized Contract Cost [Line Items] |  |  |  |  |  |  |  |  |  |  |
Royalties accrued on product sales |  |  |  |  |  |  | $ 500,000 | $ 500,000 | $ 900,000 | $ 900,000 |
Upfront payment |  |  |  |  | $ 14,000,000.0 |  |  |  |  |  |
Total revenue |  |  |  |  |  | $ 14,000,000.0 | 6,179,000 | 6,202,000 | 11,532,000 | 12,069,000 |
Amount of certain development, regulatory, and sales milestones payments eligible to receive under license agreement |  |  | $ 257,000,000 |  |  |  |  |  |  |  |
Right to terminate the agreement |  |  | 120 days |  |  |  |  |  |  |  |
Celgene License Agreement |  |  |  |  |  |  |  |  |  |  |
Capitalized Contract Cost [Line Items] |  |  |  |  |  |  |  |  |  |  |
Payment of license fees |  | $ 5,800,000 |  |  |  |  |  |  |  |  |
Related party transaction, balloon payment interest rate per annum |  | 4.00% |  |  |  |  |  |  |  |  |
Celgene License Agreement | EOC Pharma (Hong Kong) Limited |  |  |  |  |  |  |  |  |  |  |
Capitalized Contract Cost [Line Items] |  |  |  |  |  |  |  |  |  |  |
Payment received from license agreement |  |  |  |  | $ 14,000,000.0 |  |  |  |  |  |
Celgene License Agreement |  |  |  |  |  |  |  |  |  |  |
Capitalized Contract Cost [Line Items] |  |  |  |  |  |  |  |  |  |  |
Payments related to milestone |  |  |  |  |  |  | $ 0 | $ 0 | $ 0 | $ 0 |
License fees, percentage of previously outstanding payment obligation |  | 50.00% |  |  |  |  |  |  |  |  |
Due to licensor |  | $ 5,800,000 |  |  |  |  |  |  |  |  |
Celgene License Agreement | EOC Pharma (Hong Kong) Limited |  |  |  |  |  |  |  |  |  |  |
Capitalized Contract Cost [Line Items] |  |  |  |  |  |  |  |  |  |  |
Payments related to milestone |  |  |  | $ 1,000,000 |  |  |  |  |  |  |
Due to licensor |  |  |  |  |  |  |  |  |  |  | $ 200,000
Sublicense fees, percentage |  |  | 20.00% | 20.00% |  |  |  |  |  |  |
Total revenue | $ 1,000,000 |  |  |  |  |  |  |  |  |  |

X
- Definition Amount of certain development, regulatory, and sales milestones payments eligible to receive under license agreement. + References No definition available. + Details
Name: | aadi_AmountOfCertainDevelopmentRegulatoryAndSalesMilestonesPaymentsEligibleToReceiveUnderLicenseAgreement
Namespace Prefix: | aadi_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Due To Licensor + References No definition available. + Details
Name: | aadi_DueToLicensor
Namespace Prefix: | aadi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition License Fees Including Percentage Of Outstanding Payment Obligation + References No definition available. + Details
Name: | aadi_LicenseFeesIncludingPercentageOfOutstandingPaymentObligation
Namespace Prefix: | aadi_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Payment Of License Fees + References No definition available. + Details
Name: | aadi_PaymentOfLicenseFees
Namespace Prefix: | aadi_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Payments related to milestone. + References No definition available. + Details
Name: | aadi_PaymentsRelatedToMilestone
Namespace Prefix: | aadi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Related party transaction balloon payment interest rate per annum. + References No definition available. + Details
Name: | aadi_RelatedPartyTransactionBalloonPaymentInterestRatePerAnnum
Namespace Prefix: | aadi_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Right to terminate the license agreement. + References No definition available. + Details
Name: | aadi_RightToTerminateLicenseAgreement
Namespace Prefix: | aadi_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalties Were Accrued On Product Sales + References No definition available. + Details
Name: | aadi_RoyaltiesWereAccruedOnProductSales
Namespace Prefix: | aadi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Sublicense fees percentage. + References No definition available. + Details
Name: | aadi_SublicenseFeesPercentage
Namespace Prefix: | aadi_
Data Type: | dtr-types1:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Upfront Payment For License Agreement. + References No definition available. + Details
Name: | aadi_UpfrontPaymentForLicenseAgreement
Namespace Prefix: | aadi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 340 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3 + Details
Name: | us-gaap_CapitalizedContractCostLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash received from licensees for license fees during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25 + Details
Name: | us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=aadi_CelgeneLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=aadi_EOCPharmaHongKongLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=aadi_CelgeneLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |